Dr. Fagin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
530 East 74th Street
New York, NY 10021
Education & Training
- Cedars-Sinai Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1983 - 1985
- University of Buenos AiresClass of 1973
Certifications & Licensure
- CA State Medical License 1986 - Present
- FL State Medical License 2021 - Present
- NY State Medical License 2006 - 2026
- NJ State Medical License 2021 - 2025
- OH State Medical License 1995 - 2007
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member Association of American Physicians, 2001
- Top Doctors: New York Metro Area Castle Connolly, 2014
- Elected Member The American Society for Clinical Investigation, 1995
Clinical Trials
- Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244 Start of enrollment: 2009 Sep 01
- Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers Start of enrollment: 2020 Jun 26
Roles: Contact
Publications & Presentations
PubMed
- 26 citationsModulation of RNA splicing enhances response to BCL2 inhibition in leukemia.Eric Wang, Jose Mario Bello Pineda, Won Jun Kim, Sisi Chen, Jessie Bourcier
Cancer Cell. 2023-01-09 - 171 citationsAlternative transcription initiation leads to expression of a novel ALK isoform in cancerThomas Wiesner, William Lee, Anna C. Obenauf, Leili Ran, Rajmohan Murali
Nature. 2015-10-15 - 129 citationsGenomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy.Ian Ganly, Julio Cezar Ricarte Filho, Stephanie Eng, Ronald Ghossein, Luc G. T. Morris
The Journal of Clinical Endocrinology and Metabolism. 2013-03-29
Journal Articles
- Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid CancersSteven M Larson, Sofia Haque, Duan Li, R Michael Tuttle, Mona M Sabra, Alan L Ho, Eric J Sherman, Ravinder K Grewal, James A Fagin, David G Pfister, Ronald A Ghossein, The Journal of Clinical Endocrinology and Metabolism
- Radioactive Iodine-Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated with Decreased SurvivalJames Fagin, MD, The Journal of Clinical Endocrinology and Metabolism
- Methodology, Criteria and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor XenograftsJames A Fagin, Stephen D Rohl, Robert C Smallridge, Stefan K Grebe, The Journal of Clinical Endocrinology and Metabolism
Press Mentions
- Novel Agent Nixes Radioiodine Resistance in Thyroid CancerOctober 7th, 2020
- Bench to Bedside: Translating Science from the Lab to the ClinicMay 2nd, 2019
- 87th Annual Meeting NewsOctober 20th, 2017
- Join now to see all
Grant Support
- Oncogenic Events In Thyroid NeoplasiaNational Cancer Institute2006–2012
- Molecular Pathophysiology Of Thyroid Cell GrowthNational Cancer Institute2006–2012
- A Validated Resource Of Thyroid Cancer Cell Lines For Pathway DiscoveryNational Cancer Institute2009–2010
- Paracrine Igf/Gfbp Interactions In VivoNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2007
- Paracrine Igf/Gfbp Interactions In VivoNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2006
- Oncogenic Events In Thyroid NeoplasiaNational Cancer Institute1997–2006
- Molecular Pathophysiology Of Thyroid Cell GrowthNational Cancer Institute1995–2004
- Biological And Physiological Sciences Review SectionCenter For Scientific Review2001–2002
- Paracrine IGF/IGFBP Interactions In VivoNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2002
- Molecular Pathophysiology Of Thyroid Cell GrowthNational Center For Research Resources2000–2001
- N-Acetylcysteine As A Potential Treatment For Methamphetamine DependenceCenter For Scientific Review2000
- Insulin LIKE Growth Factor I In Arterial Wall InjuryNational Heart, Lung, And Blood Institute1995–1996
- Insulin LIKE Growth Factor I In Arterial Wall InjuryNational Heart, Lung, And Blood Institute1994
- Molecular Pathophysiology Of Thyroid Cell GrowthNational Cancer Institute1989–1993
- Tumor Suppressor Genes In Human Thyroid NeoplasmsNational Cancer Institute1990
- Human Growth Hormone-Secreting Hybrid CellsNational Institute Of Diabetes And Digestive And Kidney Diseases1985–1986
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: